| Bioactivity | DGKζ-IN-4 is a DGK-zeta inhibitor. DGKζ-IN-4 can be used as an active component of pharmaceutical compositions. DGKζ-IN-4 is used to treat cancers associated with immune cell activation or cancers resistant to anti-PD-1 antibody/anti-PD-11 antibody treatment[1]. |
| Name | DGKζ-IN-4 |
| CAS | 2778366-77-9 |
| Formula | C23H25ClF3N3O6 |
| Molar Mass | 531.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tu-Sekine B, et al. DGK-θ: Structure, Enzymology, and Physiological Roles. Front Cell Dev Biol. 2016 Sep 14;4:101. |
DGKζ-IN-4
CAS: 2778366-77-9 F: C23H25ClF3N3O6 W: 531.91
DGKζ-IN-4 is a DGK-zeta inhibitor. DGKζ-IN-4 can be used as an active component of pharmaceutical compositions. DGKζ-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.